132 related articles for article (PubMed ID: 21144749)
1. Preparation, in vitro screening and molecular modelling of symmetrical 4-tert-butylpyridinium cholinesterase inhibitors--analogues of SAD-128.
Musilek K; Roder J; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Opletalova V; Kuca K; Jung YS
Bioorg Med Chem Lett; 2011 Jan; 21(1):150-4. PubMed ID: 21144749
[TBL] [Abstract][Full Text] [Related]
2. Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
Musilek K; Komloova M; Zavadova V; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K; Jung YS
Bioorg Med Chem Lett; 2010 Mar; 20(5):1763-6. PubMed ID: 20138518
[TBL] [Abstract][Full Text] [Related]
3. The preparation, in vitro screening and molecular docking of symmetrical bisquaternary cholinesterase inhibitors containing a but-(2E)-en-1,4-diyl connecting linkage.
Musilek K; Pavlikova R; Marek J; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Dolezal M; Gunn-Moore F; Kuca K
J Enzyme Inhib Med Chem; 2011 Apr; 26(2):245-53. PubMed ID: 21406034
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatment.
Musilek K; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K
Eur J Med Chem; 2011 Feb; 46(2):811-8. PubMed ID: 21236521
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F
Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433
[TBL] [Abstract][Full Text] [Related]
6. Preparation, in vitro evaluation and molecular modelling of pyridinium-quinolinium/isoquinolinium non-symmetrical bisquaternary cholinesterase inhibitors.
Komloova M; Horova A; Hrabinova M; Jun D; Dolezal M; Vinsova J; Kuca K; Musilek K
Bioorg Med Chem Lett; 2013 Dec; 23(24):6663-6. PubMed ID: 24220173
[TBL] [Abstract][Full Text] [Related]
7. Mono-oxime bisquaternary acetylcholinesterase reactivators with prop-1,3-diyl linkage-Preparation, in vitro screening and molecular docking.
Musilek K; Komloova M; Holas O; Horova A; Pohanka M; Gunn-Moore F; Dohnal V; Dolezal M; Kuca K
Bioorg Med Chem; 2011 Jan; 19(2):754-62. PubMed ID: 21215642
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of asymmetrical bispyridinium compounds bearing cyano-moiety and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
Musilek K; Holas O; Kuca K; Jun D; Dohnal V; Dolezal M
Bioorg Med Chem Lett; 2006 Nov; 16(21):5673-6. PubMed ID: 16934462
[TBL] [Abstract][Full Text] [Related]
9. Monoquaternary pyridinium salts with modified side chain-synthesis and evaluation on model of tabun- and paraoxon-inhibited acetylcholinesterase.
Musilek K; Kucera J; Jun D; Dohnal V; Opletalova V; Kuca K
Bioorg Med Chem; 2008 Sep; 16(17):8218-23. PubMed ID: 18676153
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates.
Ekström F; Pang YP; Boman M; Artursson E; Akfur C; Börjegren S
Biochem Pharmacol; 2006 Aug; 72(5):597-607. PubMed ID: 16876764
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase.
Huang L; Luo Z; He F; Lu J; Li X
Bioorg Med Chem; 2010 Jun; 18(12):4475-84. PubMed ID: 20471843
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological activity, and docking studies of new acetylcholinesterase inhibitors of the bispyridinium type.
Kapková P; Stiefl N; Sürig U; Engels B; Baumann K; Holzgrabe U
Arch Pharm (Weinheim); 2003 Nov; 336(11):523-40. PubMed ID: 14639745
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships and binding mode in the human acetylcholinesterase active site of pseudo-irreversible inhibitors related to xanthostigmine.
Rizzo S; Cavalli A; Ceccarini L; Bartolini M; Belluti F; Bisi A; Andrisano V; Recanatini M; Rampa A
ChemMedChem; 2009 Apr; 4(4):670-9. PubMed ID: 19222043
[TBL] [Abstract][Full Text] [Related]
14. Reversible inhibition of human acetylcholinesterase by methoxypyridinium species.
Topczewski JJ; Lodge AM; Yasapala SN; Payne MK; Keshavarzi PM; Quinn DM
Bioorg Med Chem Lett; 2013 Nov; 23(21):5786-9. PubMed ID: 24076173
[TBL] [Abstract][Full Text] [Related]
15. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
[TBL] [Abstract][Full Text] [Related]
16. Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
Komloova M; Musilek K; Horova A; Holas O; Dohnal V; Gunn-Moore F; Kuca K
Bioorg Med Chem Lett; 2011 Apr; 21(8):2505-9. PubMed ID: 21397501
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
[TBL] [Abstract][Full Text] [Related]
18. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
[TBL] [Abstract][Full Text] [Related]
19. Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives.
Piazzi L; Cavalli A; Belluti F; Bisi A; Gobbi S; Rizzo S; Bartolini M; Andrisano V; Recanatini M; Rampa A
J Med Chem; 2007 Aug; 50(17):4250-4. PubMed ID: 17655212
[TBL] [Abstract][Full Text] [Related]
20. Affinities of bispyridinium non-oxime compounds to [(3)H]epibatidine binding sites of Torpedo californica nicotinic acetylcholine receptors depend on linker length.
Niessen KV; Seeger T; Tattersall JE; Timperley CM; Bird M; Green C; Thiermann H; Worek F
Chem Biol Interact; 2013 Dec; 206(3):545-54. PubMed ID: 24157926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
